Rheumatology
Rheumatoid Arthritis
PODCAST: Precision Rheumatology and Patient-Centered Treatment of Rheumatoid Arthritis
The use of precision medicine may revolutionize the management of rheumatoid arthritis (RA). By combining insights from synovial biopsy findings with artificial intelligence analysis of blood work, precision medicine is allowing for more personalized care that can encompass the management of not only the patient’s inflammatory symptoms but also pain from other sources that may be resistant to traditional therapies.
Bhamidipati K, Wei K. Precision medicine in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2022;36(1):101742. doi:10.1016/j.berh.2022.101742
Creagh AP, Hamy V, Yuan H, et al. Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis. NPJ Digit Med. 2024;7(1):33. doi:10.1038/s41746-024-01013-y
Das D, Choy E. Non-inflammatory pain in inflammatory arthritis. Rheumatology (Oxford). 2023;62(7):2360-2365. doi:10.1093/rheumatology/keac671
Hamy V, Llop C, Yee CW, et al. Patient-centric assessment of rheumatoid arthritis using a smartwatch and bespoke mobile app in a clinical setting. Sci Rep. 2023;13(1):18311. doi:10.1038/s41598-023-45387-7
Jonsson AH. Synovial tissue insights into heterogeneity of rheumatoid arthritis. Curr Rheumatol Rep. 2024;26(3):81-88. doi:10.1007/s11926-023-01129-2
Perera J, Delrosso CA, Nerviani A, Pitzalis C. Clinical phenotypes, serological biomarkers, and synovial features defining seropositive and seronegative rheumatoid arthritis: a literature review. Cells. 2024;13(9):743. doi:10.3390/cells13090743